
Opinion|Videos|September 27, 2024
Understanding the Clinical Burden and Prevalence of Lupus Nephritis
Panelists discuss the significant clinical and economic burdens of lupus nephritis, including the increased risk of kidney failure and death, and provide current statistics on the prevalence and incidence of lupus nephritis in various populations.
Advertisement
Episodes in this series

Now Playing
- Lupus nephritis (LN) is associated with considerable clinical and economic burdens in affected patients. Describe the clinical burden of LN on patients and their caregivers.
- What are the current statistics on the prevalence and incidence of LN in different populations?
- How many patients have systemic lupus erythematosus (SLE)?
- How often do patients with SLE present with or develop LN?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP
4
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
5